Craft

Arbor Biotechnologies

Total Funding

$215 M

Arbor Biotechnologies Summary

Company Summary

Overview
Arbor Biotechnologies is a company that provides genetic medicines through the discovery of programable DNA editors. It develops a technology platform that enables gene editing, including gene knockout, precision editing, precise excisions, and large insertions into endogenous loci. The company specializes in liver and central nervous system diseases.
Type
Private
Status
Active
Founded
2016
HQ
Cambridge, MA, US | view all locations
Website
https://arbor.bio/
Cybersecurity rating
Sectors

Key People

  • Devyn Smith

    Devyn Smith, Chief Executive Officer

  • Pam Stetkiewicz

    Pam Stetkiewicz, Chief Operating Officer

  • Ajim Tamboli

    Ajim Tamboli, Chief Financial Officer

  • David Cheng

    David Cheng, Chief Technology Officer

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    20 Acorn Park Drive #500

Footer menu